Prof Paul Bishop
Paul is a world-leading ophthalmologist and an acknowledged clinical and molecular expert in AMD, as well as an entrepreneur.
Complement Therapeutics is a clinical-stage biotechnology company developing novel therapies for complement-driven diseases.
Complement Therapeutics GmbH
Sternstrasse 21
80538 Munich
Germany
Complement Therapeutics LtdCentral Working White CityTranslation and Innovation Hub84 Wood LaneLondon, W12 0BZUnited Kingdom
Complement Therapeutics LtdLabG16Stevenage Bioscience CatalystGunnels Wood Rd,Stevenage SG1 2FXUnited Kingdom
© 2026 Complement Therapeutics